Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of the human papillomavirus vaccine in young survivors of cancer in the USA: a single-arm, open-label, phase 2, non-inferiority trial

Published:2022-01 Issue:1 Volume:6 Page:38-48
ISSN:2352-4642
Container-title:The Lancet Child & Adolescent Health
language:en
Short-container-title:The Lancet Child & Adolescent Health

Author:

Landier Wendy,Bhatia Smita,Wong F Lennie,York Jocelyn M,Flynn Jessica S,Henneberg Harrison M,Singh Purnima,Adams Kandice,Wasilewski-Masker Karen,Cherven Brooke,Jasty-Rao Rama,Leonard Marcia,Connelly James A,Armenian Saro H,Robison Leslie L,Giuliano Anna R,Hudson Melissa M,Klosky James L

Publisher

Elsevier BV

Subject

Developmental and Educational Psychology,Pediatrics, Perinatology and Child Health

Reference30 articles.

1. Human papillomavirus-attributable cancers—United States, 2012–2016;Senkomago;MMWR Morb Mortal Wkly Rep,2019

2. Worldwide burden of cancer attributable to HPV by site, country and HPV type;de Martel;Int J Cancer,2017

3. Immune function in childhood cancer survivors: a Children's Oncology Group review;Guilcher;Lancet Child Adolesc Health,2021

4. Considerations for child cancer survivors and immunocompromised children to prevent secondary HPV-associated cancers;Imburgia;Transplantation,2021

5. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers;Ojha;PLoS One,2013

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10

2. Human Papillomavirus Vaccination in Pediatric, Adolescent, and Young Adult Cancer Survivors—Opportunity to Address Gaps in Cancer Prevention and Survivorship;Vaccines;2024-01-24

3. Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administration;Human Vaccines & Immunotherapeutics;2023-06-23

4. Reasons for refusal of the human papillomavirus vaccine among young cancer survivors;Cancer;2022-12-19

5. Human papillomavirus vaccination uptake among childhood cancer survivors in Western New York;Pediatric Blood & Cancer;2022-09-12